IL17A and Alzheimer disease: In this study, we also observed that the administration of antibodies against IL17 prevented many of the pathologies induced in young AD mice that were overexpressing ASM, including BBB disruption, the formation of the pro-inflammation morphology, and the deficient phagocytic function of microglia.